Abstract: Aspects of the disclosure relate to providing improved optical character recognition (OCR). An OCR evaluation platform may generate a script for evaluating OCR performance. The platform may generate modified resources by executing OCR applications to modify original resources. Based on executing the script, the platform may generate comparative analysis information based on comparing the modified resources to the original resource. The platform may generate metric scores based on the comparative analysis information. The metric scores may be used to generate visual representations of the performance of different OCR applications. The platform may generate weighted scores representing the performance of different OCR applications. The platform may identify a preferred OCR application for performing a particular operation. The platform may store correlations between preferred OCR applications and corresponding operations.

Abstract: The invention relates to a method for synthesizing a hydroprocessing catalyst, wherein the support is prepared by mixing peptized aluminium with amorphous silica or with crystalline aluminium silicate as a catalyst component. The catalyst comprises a metal from group VIB and/or a metal from group VIIIB of the Periodic Table. The catalyst exhibits enhanced activity vis-à-vis hydrodisintegration, hydrodemetallization and hydrodesulphurization, and has a relatively stable life as a function of run time. Thus, the invention relates to a method for developing a catalyst for hydroprocessing heavy hydrocarbon feedstocks, which is characterized in that it comprises two steps: the first step involves optimization of the catalyst formulation with respect to textural properties, the number of acid sites and incorporation of the active metal; the second step involves evaluation with real feedstocks and the stability of the catalyst as is function of run time.

Abstract: An improved catalyst for hydrodemetallization of heavy crude oils and residua is disclosed. The catalyst is adopted for fixed bed hydroprocessing units. The invention is characterized for having a large pore diameter catalyst principally for hydrodemetallization of heavy oil and residue in a first reactor of a multi-reactor process. The catalyst has high demetallizing activity and high metal deposition capacity which results in good stability with time on stream (TOS). The hydrorefining catalyst is obtained by kneading a porous starting powder principally composed of gamma-alumina and having a pore capacity of 0.3-0.6 ml/g or larger and a mean pore diameter of 10 to 26 nm, extrudating and calcining, and after that supported with active metals component of elements belonging to groups VIIIB and VIB of the periodic table.

Abstract: A method for visualization of a physiological signal, comprising the steps of acquiring a time-series signal from the physiological signal, identifying a patient condition from the time-series signal, displaying a 3D image of a body, and displaying a visual indicator representative of the patient condition on the 3D image of a body.

Abstract: The present invention relates generally to a novel nucleic acid molecule. More particularly, the present invention relates to a male germ line cell specific genetic sequence in plants. Male germ line cells include generative cells and sperm cells. Even more particularly, the present invention provides a male germ line specific gene or functional equivalent thereof. This invention is also directed to the promoter of said gene or its functional derivatives and their use in generating a range of mutant plants including male sterile plants and transposon tagged plants. Preferred nucleic acid molecules of the present invention include the LGC1 gene as well as homologs and derivatives thereof.

Abstract: The present invention relates generally to reagents useful in the immunotherapeutic or immunoprophylactic treatment of allergic diseases. More particularly, the present invention provides modified allergens exhibiting reduced IgE interactivity including reduced IgE production-stimulatory activity, while retaining T-cell antigenicity, which are useful in the immunomodulation of type I allergic disease conditions. The present invention further contemplates a method of immunomodulation of allergic diseases such as type I allergic disease conditions by the administration of modified allergens exhibiting reduced IgE interactivity while retaining T-cell antigenicity.